Pocono Medical Center News
Becker's Healthcare recently released their 2015 edition of the "150 Great Places to Work in Healthcare" and among them is Pocono Medical Center. This is the second year in a row that Pocono Medical Center was recognized and joins Children's Hospital of Philadelphia as one of only two Pennsylvania health systems to achieve this special recognition.
"This kind of national recognition reflects the passion, commitment, talent, and hard work of our over 2,000 health system colleagues and Medical Staff, Jeff Snyder, President and CEO, Pocono Medical Center said. "Their daily dedication to healing and caring for our community is unmatched."
Becker's 2015 list features hospitals and health systems, medical groups, ambulatory surgery centers, home health providers, consulting firms, technology providers, among others. The actual list is developed through a combination of nominations and editorial research. In fact, the recognized organizations like Pocono Medical Center are chosen for their benefits, wellness programs, commitment to diversity and inclusion, professional development opportunities, employee satisfaction, and work-life balance.
“It is truly a privilege to work at Pocono Medical Center with such wonderful colleagues that are devoted to serving others while delivering excellent care, close to home,” continued Mr. Snyder.
Individuals can learn more about Becker's Healthcare and the 2015 edition by visiting, http://www.beckershospitalreview.com/lists/150-great-places-to-work-in-healthcare-2015.html. To learn more about employment at Pocono Medical Center, please visit http://www.poconohealthsystem.org/?id=242&sid=1.
Pocono Medical Center Designated an ACR Breast Imaging Center of Excellence
Pocono Medical Center's Bartonsville Healthcare Center has been designated a Breast Imaging Center of Excellence by the American College of Radiology (ACR). The ACR only awards facilities the status of a Breast Imaging Center of Excellence when they have earned accreditation in mammography, stereotactic breast biopsy, and breast ultrasound (including ultrasound-guided breast biopsy).
"This accreditation demonstrates the commitment we have to our patients and the community to ensure we are consistently providing the most advanced technologies and compassionate care," notes Elizabeth Wykpisz, RN, MSN, MBA, DrNP (c), NEA-BC, CENP, Chief Operating Officer/Chief Nursing Officer, Pocono Medical Center.
Peer-review evaluations, conducted in each breast imaging modality by board-certified physicians and medical physicists who are experts in the field, have determined that Pocono Medical Center has achieved high practice standards in image quality, personnel qualifications, equipment, quality control procedures, and quality assurance programs. The ACR is a national professional organization serving more than 36,000 diagnostic/interventional radiologists, radiation oncologists, nuclear medicine physicians, and medical physicists with programs focusing on the practice of medical imaging and radiation oncology and the delivery of comprehensive health care services.
To learn more about the ACR, please visit http://www.acr.org/ and you may also visit http://www.poconohealthsystem.org/ to experience excellent care, close to home.
Pocono Medical Center Completes Landmark Study on Reducing Hospital Contamination
and Hospital Acquired Infections
Pocono Medical Center (PMC) today announced that it has completed a landmark study aimed at reducing hospital contamination and hospital acquired infections (HAIs) by using Dilute Hydrogen Peroxide (DHP) Technology. The study has demonstrated very promising results in both environmental disinfection and in the control of infections. The first phase of the study, which showed a reduction in hospital bacterial and fungal growth, has been selected for presentation at the annual meeting of the Association for Professionals in Infection Control (APIC) Convention, which is the nation’s leading scientific convention dedicated to infection control.
In addition, the research abstract has just received the William A. Rutala Award, one of the most prestigious awards in the field of infection control. The detailed results of the study will be made available after it is presented at the APIC national meeting. Pocono Medical Center was chosen to be the first healthcare site in the nation for the integration of DHP into its environmental disinfection strategy. The primary investigator for the study is Charles K. Herman, M.D., Chief Medical Executive, Chief of Surgery, and Director of Plastic Surgery at PMC. The study is being sponsored by Lee Antimicrobial Solutions (LAMS) of Armonk, NY, and Delafield Solutions of Huntsville, AL. Dr. Herman worked with LAMS, Delafield Solutions, and hospital leadership at PMC to bring this innovative technology to the hospital.
"DHP technology makes new infection control strategies possible because it can be used 24/7/365 to provide continuous disinfection of the our patient care areas. This is a significant advantage over competing modalities, such as ultraviolet light and peroxide vapor," said Dr. Herman. “We have been using it for over six months on one of our patient care units, and the results show great promise. Dilute concentrations of peroxide have been shown to be effective at reducing growth of bacteria, fungi, and viruses. "
“Pocono Medical Center has historically demonstrated HAI rates that are very favorable when compared to other hospitals. However, all hospitals face the risk of infections and the increasing threat of multi-drug resistant bacteria. This new capability provides us with another tool in the national fight against HAIs, which has a direct cost to the US healthcare system of over $30 billion annually,” continued Dr. Herman. “This is good news for everyone and most especially our patients.”
DHP technology automatically produces Dilute Hydrogen Peroxide from humidity and oxygen in the air itself, then puts a small amount in every bit of air that is hundreds of times less than is naturally made by our own lungs. DHP disinfects viruses, bacteria, and fungi in the air, and on all surfaces in contact with the air. The technology is also inexpensive to use, requires almost no maintenance, and costs less than other systems on the market. LAMS has received three U.S. patents and nine international patents for DHP Technology so far, and it is classified by the EPA as a pesticide device technology.